rac-N-(4-(3,4-Difluorophenyl)piperidin-3-yl)-4-(1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide (2R,3R)-2,3-Dihydroxysuccinate

ID: ALA4570911

PubChem CID: 155562963

Max Phase: Preclinical

Molecular Formula: C24H26F2N4O8

Molecular Weight: 386.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1nccc1-c1coc(C(=O)NC2CNCCC2c2ccc(F)c(F)c2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O

Standard InChI:  InChI=1S/C20H20F2N4O2.C4H6O6/c1-26-18(5-7-24-26)13-9-19(28-11-13)20(27)25-17-10-23-6-4-14(17)12-2-3-15(21)16(22)8-12;5-1(3(7)8)2(6)4(9)10/h2-3,5,7-9,11,14,17,23H,4,6,10H2,1H3,(H,25,27);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1

Standard InChI Key:  BWCDEAQBPYLODD-LREBCSMRSA-N

Molfile:  

     RDKit          2D

 38 40  0  0  0  0  0  0  0  0999 V2000
   23.2288   -6.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9427   -5.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6608   -6.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3746   -5.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2288   -6.9515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5149   -5.7120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.3746   -4.8870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.0885   -6.1265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.6608   -6.9515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.9427   -4.8870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4188   -2.3749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4177   -3.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1325   -3.6151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8489   -3.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8461   -2.3713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1306   -1.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1289   -4.4374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4125   -4.8485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4104   -5.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1229   -6.0863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8392   -5.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8431   -4.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6991   -4.4341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9836   -4.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2703   -4.4303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9815   -5.6696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1894   -3.6093    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.3829   -3.4356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9685   -4.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5190   -4.7635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1466   -4.2316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5962   -3.6171    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8417   -3.9508    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9258   -4.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7323   -4.9450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7697   -2.8106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5589   -1.9561    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.1282   -1.1371    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  5  2  0
  1  6  1  0
  4  7  2  0
  4  8  1  0
  3  9  1  6
  2 10  1  6
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 13 17  1  0
 18 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 25  2  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  2  0
 29 31  1  0
 32 36  1  0
 15 37  1  0
 16 38  1  0
M  END

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.40Molecular Weight (Monoisotopic): 386.1554AlogP: 2.83#Rotatable Bonds: 4
Polar Surface Area: 72.09Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 1.99CX LogD: 0.20
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.72Np Likeness Score: -1.18

References

1. Dong X, Zhan W, Zhao M, Che J, Dai X, Wu Y, Xu L, Zhou Y, Zhao Y, Tian T, Cheng G, Jin Z, Li J, Shao Y, He Q, Yang B, Weng Q, Hu Y..  (2019)  Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design.,  62  (15): [PMID:31298542] [10.1021/acs.jmedchem.9b00891]

Source